Bender Robert & Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Bender Robert & Associates’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$60K	Hold
2022 Q2	$90K	Buy
2021 Q2	–	Sell
2021 Q1	$351K	Buy